Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: November 25, 2009
Last updated: July 29, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)